Takehiro Higashi

Kitakyushu, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Sequential development of BCR::ABL1-positive chronic myeloid leukemia during treatment of JAK2 V617F-positive essential thrombocythemia

Sequential development of BCR::ABL1-positive chronic myeloid leukemia during treatment of JAK2 V617F-positive essential thrombocythemia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: May 13, 2026

Early and Long-Lasting Hematologic Recovery in a Young Adult With Severe Aplastic Anemia Treated With Romiplostim, Horse-Anti-Thymocyte Globulin (ATG), and Cyclosporine A: A Case Report.

Early and Long-Lasting Hematologic Recovery in a Young Adult With Severe Aplastic Anemia Treated With Romiplostim, Horse-Anti-Thymocyte Globulin (ATG), and Cyclosporine A: A Case Report.

Journal: Cureus

Published: October 15, 2025

Interdisciplinary Approach to Diagnostic Challenges: A Case Study of Cardiac Amyloid Light-Chain (AL) Amyloidosis, Multiple Myeloma, and Ductal Carcinoma In Situ.

Interdisciplinary Approach to Diagnostic Challenges: A Case Study of Cardiac Amyloid Light-Chain (AL) Amyloidosis, Multiple Myeloma, and Ductal Carcinoma In Situ.

Journal: Cureus

Published: May 01, 2025

Viral and Fungal Infections Early After HLA-Mismatched Hematopoietic Stem Cell Transplantation Using Low-Dose Antithymocyte Globulin in High-Risk Patients With Hematological Malignancies Not in Remission.

Viral and Fungal Infections Early After HLA-Mismatched Hematopoietic Stem Cell Transplantation Using Low-Dose Antithymocyte Globulin in High-Risk Patients With Hematological Malignancies Not in Remission.

Journal: Clinical lymphoma, myeloma & leukemia

Published: October 30, 2024

Successful polatuzumab vedotin and rituximab therapy for post-CAR-T relapse of diffuse large B-cell lymphoma

Successful polatuzumab vedotin and rituximab therapy for post-CAR-T relapse of diffuse large B-cell lymphoma

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: April 03, 2024

Mogamulizumab for post-transplant relapse of adult T-cell leukemia/lymphoma: a case study.

Mogamulizumab for post-transplant relapse of adult T-cell leukemia/lymphoma: a case study.

Journal: International journal of hematology

Published: May 29, 2022

Average lifespan shortened due to Hodgkin lymphoma, non-Hodgkin lymphoma, multiple myeloma, and leukemia in Japan, 1990-2015.

Average lifespan shortened due to Hodgkin lymphoma, non-Hodgkin lymphoma, multiple myeloma, and leukemia in Japan, 1990-2015.

Journal: Leukemia & lymphoma

Published: April 25, 2022

Reduced-intensity haploidentical peripheral blood stem cell transplantation using low-dose thymoglobulin for aggressive adult T cell leukemia/lymphoma patients in non-complete remission.

Reduced-intensity haploidentical peripheral blood stem cell transplantation using low-dose thymoglobulin for aggressive adult T cell leukemia/lymphoma patients in non-complete remission.

Journal: Annals of hematology

Published: April 13, 2019

Primary breast diffuse large B-cell lymphoma developing subsequent to estramustine therapy for prostate cancer

Primary breast diffuse large B-cell lymphoma developing subsequent to estramustine therapy for prostate cancer

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: January 16, 2018

HTLV-I-associated posttransplant lymphoproliferative disorder following virus transmission from recipient to donor cells.

HTLV-I-associated posttransplant lymphoproliferative disorder following virus transmission from recipient to donor cells.

Journal: Blood

Published: May 11, 2017

Efficacy and Safety of THP-COP for Diffuse Large B-Cell Lymphoma

Efficacy and Safety of THP-COP for Diffuse Large B-Cell Lymphoma

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: February 09, 2017

HLA-haploidentical hematopoietic stem cell transplantation with low-dose thymoglobulin GVHD prophylaxis for an adult T cell leukemia/lymphoma patient treated with pretransplant mogamulizumab.

HLA-haploidentical hematopoietic stem cell transplantation with low-dose thymoglobulin GVHD prophylaxis for an adult T cell leukemia/lymphoma patient treated with pretransplant mogamulizumab.

Journal: Annals of hematology

Published: September 29, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026